{"id":888080,"date":"2025-09-19T17:32:21","date_gmt":"2025-09-19T21:32:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/"},"modified":"2025-09-19T17:32:21","modified_gmt":"2025-09-19T21:32:21","slug":"levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/","title":{"rendered":"Levi & Korsinsky Reminds Novo Nordisk A\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO"},"content":{"rendered":"
\n

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Novo Nordisk A\/S<\/strong> (“Novo” or the “Company”) (NYSE: NVO) of a class action securities lawsuit.<\/p>\n

\n CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of Novo investors who were adversely affected by alleged securities fraud between May 7, 2025 and July 28, 2025. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n

\n https:\/\/zlk.com\/pslra-1\/novo-nordisk-a-s-lawsuit-submission-form-3?prid=168147&wire=3<\/a>\n <\/p>\n

\n NVO<\/strong> investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com<\/a>\u00a0or by telephone at (212) 363-7500.<\/p>\n

\n CASE DETAILS: <\/strong>According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing material adverse facts concerning the true state of Novo\u2019s growth potential; notably, that its asserted potential to capitalize on the compounded market greatly understated the potential impact of the personalization exception to the compounded GLP-1 exclusion and overstated the likelihood such patients would switch to Novo\u2019s branded alternatives, and further greatly overstated the potential GLP-1 market or otherwise Novo\u2019s capability to penetrate said markets to achieve continued growth. On July 29, 2025, Novo announced it was lowering its sales and profit outlook ahead of reporting its results for the second quarter of fiscal year 2025. The Company attributed the guide down on \u201clowered growth expectations for the second half of 2025\u201d for both Wegovy and Ozempic due to \u201cthe persistent use of compounded GLP-1s, slower-than-expected market expansion and competition.\u201d Following this news, the price of Novo\u2019s common stock declined dramatically. From a closing market price of $69.00 per share on July 28, 2025, Novo\u2019s stock price fell to $53.94 per share on July 29, 2025, a decline of about 21.83% in the span of just a single day.<\/p>\n

\n WHAT’S NEXT? <\/strong>If you suffered a loss in Novo during the relevant time frame, you have until September 30, 2025<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.<\/p>\n

\n NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.<\/strong><\/p>\n

\n WHY LEVI & KORSINSKY: <\/strong>Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n

\n CONTACT:<\/strong>
\n
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com<\/a>
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Novo Nordisk A\/S (“Novo” or the “Company”) (NYSE: NVO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Novo investors who were adversely affected by alleged securities fraud between May 7, 2025 and July 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/novo-nordisk-a-s-lawsuit-submission-form-3?prid=168147&wire=3 NVO investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing … <\/p>\n

Continue reading “Levi & Korsinsky Reminds Novo Nordisk A\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-888080","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLevi & Korsinsky Reminds Novo Nordisk A\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Levi & Korsinsky Reminds Novo Nordisk A\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Novo Nordisk A\/S (“Novo” or the “Company”) (NYSE: NVO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Novo investors who were adversely affected by alleged securities fraud between May 7, 2025 and July 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/novo-nordisk-a-s-lawsuit-submission-form-3?prid=168147&wire=3 NVO investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing … Continue reading "Levi & Korsinsky Reminds Novo Nordisk A\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-19T21:32:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc1MiM3MTU0ODU5IzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Levi & Korsinsky Reminds Novo Nordisk A\\\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO\",\"datePublished\":\"2025-09-19T21:32:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\\\/\"},\"wordCount\":511,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzMTc1MiM3MTU0ODU5IzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\\\/\",\"name\":\"Levi & Korsinsky Reminds Novo Nordisk A\\\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzMTc1MiM3MTU0ODU5IzIwMjA0MjY=\",\"datePublished\":\"2025-09-19T21:32:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzMTc1MiM3MTU0ODU5IzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzMTc1MiM3MTU0ODU5IzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Levi & Korsinsky Reminds Novo Nordisk A\\\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Levi & Korsinsky Reminds Novo Nordisk A\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/","og_locale":"en_US","og_type":"article","og_title":"Levi & Korsinsky Reminds Novo Nordisk A\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO - Market Newsdesk","og_description":"NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Novo Nordisk A\/S (“Novo” or the “Company”) (NYSE: NVO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Novo investors who were adversely affected by alleged securities fraud between May 7, 2025 and July 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/novo-nordisk-a-s-lawsuit-submission-form-3?prid=168147&wire=3 NVO investors may also contact Joseph E. Levi, Esq. via email at\u00a0jlevi@levikorsinsky.com\u00a0or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing … Continue reading \"Levi & Korsinsky Reminds Novo Nordisk A\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-19T21:32:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc1MiM3MTU0ODU5IzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Levi & Korsinsky Reminds Novo Nordisk A\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO","datePublished":"2025-09-19T21:32:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/"},"wordCount":511,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc1MiM3MTU0ODU5IzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/","name":"Levi & Korsinsky Reminds Novo Nordisk A\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc1MiM3MTU0ODU5IzIwMjA0MjY=","datePublished":"2025-09-19T21:32:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc1MiM3MTU0ODU5IzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzMTc1MiM3MTU0ODU5IzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-reminds-novo-nordisk-a-s-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-30-2025-nvo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Levi & Korsinsky Reminds Novo Nordisk A\/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 \u2013 NVO"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/888080","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=888080"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/888080\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=888080"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=888080"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=888080"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}